Lost in translation: epidemiology, risk, and Alzheimer disease

Arch Neurol. 2010 Jan;67(1):107-11. doi: 10.1001/archneurol.2009.311.

Abstract

There is increasing emphasis on interdisciplinary “translation” in biomedical research. A major push towards prevention of Alzheimer's Disease is spawning translational research that should span basic, clinical, and population investigations. Epidemiological studies, which address our understanding of risk and protective factors for disease at the population level, are contributing less than they could to translational research. In part, this is because the key concept of risk is being “lost in translation,” muddling interpretations and leading to interdisciplinary frustrations. Two epidemiologists offer a framework for resolving some of the confusion.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / prevention & control
  • Causality
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / standards
  • Community-Institutional Relations / standards
  • Environmental Exposure
  • Epidemiologic Methods*
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Incidence
  • Interdisciplinary Communication
  • Prevalence
  • Risk Assessment / methods
  • Risk Factors
  • Risk Reduction Behavior
  • Translational Research, Biomedical / methods*
  • Translational Research, Biomedical / trends